Pyrimidine Based Inhibitors Targeting Glutathione S‐Transferase in Phase II Detoxification: Antioxidant, ADMET, Docking, and Molecular Dynamics Evaluation

Documenti analoghi

• The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4‐Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S‐Transferase
  di: Fikret Türkan, et al.
  Pubblicazione: (2025)
• New methyl/benzyl‐1,2,4‐triazole‐3‐one Derivatives: Synthesis, Characterization (IR, NMR), Antidiabetic, Anti‐Alzheimer, and Molecular Docking Study
  di: Fatih Çelik, et al.
  Pubblicazione: (2025)
• Synthesis, Biological Evaluation, in Silico ADMET Prediction, Molecular Docking and Dynamics Studies of 4‐phenoxyphenyl‐thiazole‐Schiff Base Derivatives
  di: Setu Karmokar, et al.
  Pubblicazione: (2025)
• Synthesis and Biological Evaluation of Thiazolyl–Pyrimidine Hybrids as Potential Antiproliferative Agents With Molecular Docking Insights
  di: Sobhi M. Gomha, et al.
  Pubblicazione: (2025)
• Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked‐Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies
  di: Songül Bayrak, et al.
  Pubblicazione: (2024)